Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MEMOLI, B.
Right arrow Articles by GUIDA, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MEMOLI, B.
Right arrow Articles by GUIDA, B.
J Am Soc Nephrol 10:2171-2176, 1999
© 1999 American Society of Nephrology

Hemodialysis-Related Lymphomononuclear Release of Interleukin-12 in Patients with End-Stage Renal Disease

BRUNO MEMOLI*, LUIGI MARZANO*, VINCENZO BISESTI*, MICHELE ANDREUCCI* and BRUNA GUIDA{dagger}

* Department of Nephrology, University Federico II of Naples, Italy.
{dagger} Department of Physiology, University Federico II of Naples, Italy.

Correspondence to Dr. Bruno Memoli, Department of Nephrology, University Federico II of Naples, Italy, Via S. Pansini 5 (Ed. 5), 80131 Napoli, Italy. Phone and Fax: +39/817462641; E-mail: memoli{at}unina.it

Abstract. Interleukin-12 (IL-12) is a cytokine produced by peripheral blood mononuclear cells (PBMC) that causes interferon-{gamma} (IFN-{gamma}) production and enhancement of cell-mediated cytotoxicity. To clarify the role of hemodialysis biocompatibility on IL-12 production and uremic immunodeficiency, we have studied the IL-12 and IFN-{gamma} release by PBMC harvested from 12 patients dialyzed with cuprophan membrane (CU), eight patients dialyzed with polymethylmethacrylate membrane (PMMA), and eight nondialyzed uremic patients (UR). Ten healthy subjects constituted the control group (CON). PBMC were cultured for 48 h with and without nonspecific mitogen stimulation. In unstimulated conditions, CU showed an IL-12 PBMC production higher than CON, UR, and PMMA (46.67 ± 30.13 versus 2.56 ± 1.38, 6.16 ± 7.09, and 4.62 ± 4.76 pg/ml, respectively; P < 0.01). IL-12 production was correlated with C3a concentration measured at the outlet of hemodialyzer after 15 min of dialysis (r = 0.69, P < 0.01). IL-12 release in CU remained unchanged under mitogen stimulation (44.34 ± 23.86 pg/ml) and was lower than in CON, UR, and PMMA (66.0 ± 12.41, 68.37 ± 25.78, and 67.75 ± 22.61 pg/ml, respectively; P < 0.05). IFN-{gamma} production was similar, in unstimulated conditions, in all groups. Under stimulation, IFN-{gamma} release was lower in CU (13.42 ± 12.04 IU/ml) than in CON, UR, and PMMA (51.84 ± 30.74, 32.16 ± 13.86, and 32.16 ± 13.86 IU/ml, respectively; P < 0.01). These results demonstrate that hemodialysis with CU induces monocyte activation with an enhanced release of IL-12. On the contrary, stimulated PBMC production of both IL-12 and IFN-{gamma} is lower in these patients than in CON, UR, and PMMA. The altered release of these cytokines could play a role in cell-mediated immunodeficiency of the uremic patients dialyzed with CU.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
V. E. Andreucci, D. N. S. Kerr, and J. D. Kopple
Rights of chronic renal failure patients undergoing chronic dialysis therapy
Nephrol. Dial. Transplant., January 1, 2004; 19(1): 30 - 38.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. C. Cooper, A. Mikhail, M. W. Lethbridge, D. M. Kemeny, and I. C. Macdougall
Increased Expression of Erythropoiesis Inhibiting Cytokines (IFN-{gamma}, TNF-{alpha}, IL-10, and IL-13) by T Cells in Patients Exhibiting a Poor Response to Erythropoietin Therapy
J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1776 - 1784.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. C. Cooper, C. P. Breen, B. Vyas, J. Ochola, D. M. Kemeny, and I. C. Macdougall
Poor response to recombinant erythropoietin is associated with loss of T-lymphocyte CD28 expression and altered interleukin-10 production
Nephrol. Dial. Transplant., January 1, 2003; 18(1): 133 - 140.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
W. H. Horl
Hemodialysis Membranes: Interleukins, Biocompatibility, and Middle Molecules
J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S62 - 71.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673